Carmichael Hill & Associates, Inc. - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 173 filers reported holding KURA ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
Carmichael Hill & Associates, Inc. ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$183
-13.7%
200.0%0.00%
Q2 2023$212
-13.5%
200.0%0.00%
Q1 2023$245
-1.2%
200.0%0.00%
Q4 2022$248200.0%0.00%
Q3 2022$0200.0%0.00%
Q2 2022$0200.0%0.00%
Q1 2022$0200.0%0.00%
Q4 2021$0200.0%0.00%
Q3 2021$0200.0%0.00%
Q2 2021$0
-100.0%
200.0%0.00%
-100.0%
Q1 2021$1,000200.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 206,307$3,363,00011.31%
Foresite Capital Management IV, LLC 1,307,982$21,320,00010.39%
EcoR1 Capital, LLC 4,608,529$75,119,0005.55%
Prosight Management, LP 685,000$11,166,0004.79%
ACUTA CAPITAL PARTNERS, LLC 872,500$14,222,0004.11%
BVF INC/IL 2,775,882$45,247,0002.79%
VR Adviser, LLC 575,000$9,373,0002.24%
ALETHEA CAPITAL MANAGEMENT, LLC 216,171$3,524,0002.06%
DAFNA Capital Management LLC 294,260$4,796,0001.38%
Vivo Capital, LLC 1,050,000$17,115,0001.23%
View complete list of KURA ONCOLOGY INC shareholders